Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Agrawal P, David KA, Chen Z, Sundaram S, Kim S-, Vaca R, et al. EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leuk Lymphoma. 2023;64(5):1026-1034.

Sarwate M, Khaitan N, Alpert L, Tavberidze N, Zhang W, Panarelli N, et al. Gastric Glandular Siderosis but not Lamina Propria Siderosis is Associated With High Serum Ferritin Levels. Am J Surg Pathol. 2023;47(9):1052-1058.

Hao Y, Lynch K, Fan P, Jurtschenko C, Cid M, Zhao Z, et al. Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry. J Appl Lab Med. 2023;8(1):53-66.

Jessurun J, Orr C, McNulty SN, Hagen CE, Alnajar H, Wilkes D, et al. GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions. Am J Surg Pathol. 2023;47(1):65-73.

Gereta S, Hung M, Alexanderani MK, Robinson BD, Hu JC. Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy. Urology. 2023;181:31-37.

Waterton K, Magro CM, Lipner SR. Nail Unit Squamous Cell Carcinoma with Onycholemmal Features: Case Report and Review of the Literature. Skin Appendage Disord. 2023;9(4):284-290.

Suknuntha K, Geyer JT, Patel KP, Weinberg OK, Rogers HJ, Lake JI, et al. Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation. Leuk Res. 2023;127:107033.

Hongo JA, de Castro GM, Menezes AP, Picorelli AC, da Silva TT, Imada EL, et al. CALANGO: A phylogeny-aware comparative genomics tool for discovering quantitative genotype-phenotype associations across species. Patterns (N Y). 2023;4(6):100728.

Goyal A. Role of Fine Needle Aspiration Cytology in the Diagnosis of Gynecologic Tumors. Acta Cytol. 2023;67(2):195-212.

Kim G, Karadal-Ferrena B, Qin J, Sharma VP, Oktay IS, Lin Y, et al. Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy. NPJ Breast Cancer. 2023;9(1):52.